Loading
Indegene Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Anita Nair, was filed 20 Mar 2026.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€1M
6 ops. · all time
Sell Volume
€1M
16 ops. · all time
Who traded when
BuySaleBina Patil4 sales
Bina Sanjeev Patil3 sales
Rajesh Bhaskaran Nair3 buys
Amit Gupta1 sale
Anita Nair1 buy
BPC Genesis Fund I SPV Ltd & PAC1 sale
+7 other insiders
Since the insiders bought
- +25.7%Entry ₹423.50 · Close at T+90 ₹532.40
- -5.0%Entry ₹553.50 · Close at T+90 ₹525.60
- -12.4%Entry ₹596.70 · Close at T+365 ₹522.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Indegene Limited Strong Buy (bullish), based on 8 analysts. Average price target: ₹659.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,978 of 26,284 companies
61.4
score / 100
Value44
Quality79
FCF yld4.4%
Earn yld2.9%
EV/EBITDA20.8x
ROE14%
Gross mgn·
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹588.30
Analyst consensus
8 analystsStrong buy
₹500.00Target ₹659.75(+12%)₹735.00
Income statement
Revenue₹35.1B
EBITDA₹6.7B19% margin
Net income₹4B10.5% margin
Valuation
PER (trailing)34.9x
PER (forward)21.7x
P/Book4.5x
Beta0.75
Balance sheet & cash
Market cap₹141.7B
Total debt₹1.4B
Free Cash Flow₹6.1B
Debt / Equity5%
Profitability & ownership
ROE13.9%
ROA7.7%
% insiders55.5%
% institutions27.8%
Last declaration on 28 August 2026
Declarations22 total
7,190,255 shares-MarketSEBI:3e02eb9a8d95451e7eb6534f74d035155e8ac94f
13,862,223 shares-MarketSEBI:8f1cef4ebe31d2830d1fe64b74434184fc82386f
34,000 shares@ ₹526.60100.0% of flowEquity SharesMarket SaleSEBI:e2ea38fb40476aec22059df1c4644a9daa0d7f53
22,230 shares@ ₹449.7637100.0% of flowEquity SharesSEBI:358f1c7b4c13a22753d356fb62ebf147a501c47e
Canonical exit: 17 Jun 2026 (T+90)
60,000 shares@ ₹486.7252100.0% of flowEquity SharesSEBI:46b7309a0a21096c85128a152624ab9cbe957a7d
10,000 shares@ ₹512.5695100.0% of flowEquity SharesSEBI:a94976b03ea0ad9c8329910cd0823ceb76ab1915
13,570 shares@ ₹514.731761.2% of flowEquity SharesSEBI:b1a5369fecc2dddf6874d95684c39d55008cdc44
2,200 shares@ ₹516.8582100.0% of flowEquity SharesSEBI:4f2d915286358ec51a732951e2de10aec8fa12d0
5,930 shares@ ₹524.0070.6% of flowEquity SharesSEBI:f9d1cfeb2a491fe3e5dba264e5d41a0330a3eb05
2,000 shares@ ₹515.849523.4% of flowEquity SharesSEBI:ef0709c40b05ddda78ac15ca0ed507884f0f85a0
500 shares@ ₹525.706.0% of flowEquity SharesSEBI:7a772eb8e5524afc7643bb3d7b19c9ab92f2c110
5,930 shares@ ₹523.685527.4% of flowEquity SharesSEBI:e295d2b9784d3faea6ed2a77b2a6b82ccbaf0a54
500 shares@ ₹525.702.3% of flowEquity SharesSEBI:865c8bcd019ffcfccf381439a3c4459e5c1c4975
2,000 shares@ ₹515.859.0% of flowEquity SharesSEBI:0b75bad2eed4b563363df6b510f2134a630f16d4
9,150 shares@ ₹546.20425.5% of flowEquity SharesSEBI:f14298b2d17fab9c2fe6e3121136008ce1b554ab
Canonical exit: 4 Dec 2025 (T+90)
17,000 shares@ ₹599.1874100.0% of flowEquity SharesSEBI:49a53c926980cb65973e304df89490cd9226ac33
Canonical exit: 24 Mar 2025 (T+90)
25,000 shares@ ₹598.263919.0% of flowEquity SharesSEBI:d80b843013d75fb5ceb01860b23eee1bf510e9a9
Canonical exit: 23 Mar 2025 (T+90)
16,500 shares@ ₹606.5242100.0% of flowEquity SharesSEBI:9d6c1a1f4a714b6f58565bbc55d21e4c0c6935c2
Canonical exit: 20 Mar 2025 (T+90)
100,000 shares@ ₹595.809575.5% of flowEquity SharesSEBI:f4a7f6c2680b402778a724ac2235fa47c795585b
Canonical exit: 17 Mar 2025 (T+90)
20,000 shares@ ₹627.6371100.0% of flowEquity SharesSEBI:57582329c662e8d1afde781c6feb4302567cbd16
620 shares@ ₹672.69031.2% of flowEquity SharesSEBI:72db5c3b72ac36518cc206e0c77db9a67d471c11
49,380 shares@ ₹669.399698.8% of flowEquity SharesSEBI:179d16bf7f9abcf550fe075526dd28d62d1bb0e4
22 of 22 declarations
About Indegene Limited
Indegene Limited published 22 filings from 14 filers between September 26, 2024 and August 28, 2026, a short record with no grant or option exercise. The Indian healthcare company is listed on the Bombay stock exchange and valued at INR 141.7 billion; its insiders hold 55.5%.
The largest purchase is by Rajesh Bhaskaran Nair, EUR 666,532 on December 17, 2024, followed by EUR 167,394 on December 23, 2024 by the same filer and EUR 114,931 by Manish Gupta on December 24, 2024. Between December 17 and December 24, 2024, 3 insiders bought EUR 1,062,204 in total. The record's 6 purchases total EUR 1.2 million (median EUR 114,139) and form 27% of market trades.
Read moreShow less
The 16 sales (14 with an amount) represent EUR 1.1 million, with a median of EUR 30,394. The largest, EUR 353,424, is by Suhas Prabhu on September 26, 2024; next come Sameer Narendrakumar Lal, EUR 272,586 on February 25, 2026, and Shouvanik Chatterjee, filed as Designated Person, EUR 162,616 on June 12, 2026. Bina Patil signs 4 filings, all sales, and Bina Sanjeev Patil 3. The 14 filings of the last twelve months count 1 purchase and 13 sales. They come out 1 day after the trade in median.
